Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Conference
AASP Northeast Trade Show
Visit Us at the Exhibit Booth Northeast is an eve
Workers' Comp
White Paper
Substance Misuse Recovery Network
Specialty Networks Play a Key Role in Fighting Opioid Misuse For all the progress our nation has made in reducing opioid prescriptions, m
Mitchell
News Release
In a Hazy Election, Marijuana Is a Clear Winner
As ballots continue to be counted around the country, with some races still too close to call, voters were much more certain on their support for m
Mitchell
News Release
Evzio Naloxone Auto-Injectors Discontinued
Kaleo, the makers of Evzio, have recently discontinued the prod
Workers' Comp
News Release
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an
Workers' Comp
Blog
Look for a Broken Spirit, Not Just a Broken Bone
As featured on the workcompwire.com blog, this piece was contributed by Tammy Bradly, Vice President, Clinical Product Develo